Cat. No.: DIA-0230497
Product Information | |
---|---|
CAS No. | 1384426-12-3 |
Formula | C16H14BrNO5S |
Molecular Weight | 412.26 |
SMILES | OC1=CC(=CC(=C1O)O)CNC(=S)/C=C/C2=CC(=C(O)C(=C2)Br)O |
Product Description | NT157, a selective inhibitor of IRS-1/2(insulin receptor substrate), has the potential to inhibit IGF-1R and STAT3 signaling pathways in cancer cells and stroma cells of TME leading to a decrease in cancer cell survival. |
Format & Storage | |
---|---|
Purity | > 99% |
Shipping | Shipped on dry ice. |
Storage | Powder: -20 °C, 3 years; 4 °C, 2 years In solvent: -80 °C, 6 months; -20 °C, 1 month |
Solubility Overview | Soluble in DMSO |
Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.